Markel Corporation
CorpDigest
Markel Corporation
Annual Revenue
Last reviewed: 2026-06-10 · By Swet Parvadiya
FY2025 Revenue
$13.1B
▲ 7.4% vs FY2024 ($12.2B)
Markel Corporation reported $13.1B in revenue for fiscal year 2025. This represents a growth of 7.4% compared to the 2024 figure of $12.2B.
Markel Ventures generated over $1.2 billion in EBITDA in FY2024 from a portfolio of non-insurance manufacturing and service businesses — a cash flow stream that arrives every quarter regardless of whether a hurricane hits Florida or a cyberattack strikes a Lloyd's syndicate. At roughly a 22% operating margin, the Ventures portfolio represents a permanent, non-callable capital base that insulates the broader holding company from the natural volatility of insurance cycles. Total revenues grew from $11.6 billion in FY2023 to $12.2 billion in FY2024, with FY2025 projected at $13.1 billion. Net income of $1.6 billion in FY2024 reflected strong underwriting results combined with investment portfolio gains. Market capitalization stood at $21.5 billion. The insurance segment's 11.4% combined ratio in FY2024 was a standout result. The three major loss events that tested the model — the 9/11 attacks in 2001, the global financial crisis in 2008, and Hurricanes Harvey and Irma in 2017 — each required the decentralized structure to absorb shocks without a capital raise. Individual line managers hold actual binding authority, which means they can also stop writing when pricing deteriorates, creating a natural discipline that centralized pricing committees cannot replicate. The investment portfolio's equity orientation — the Gayner legacy since 1986 — produces returns correlated to equity markets rather than bond yields. In long-term equity bull markets, it compounds. The entire Markel financial model is a long-term compound interest machine, and the 14% book value per share growth in FY2024 is the metric that proves the machine is still running correctly.
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.